These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38103650)

  • 1. Virus-containing migrasomes enable poxviruses to evade tecovirimat/ST-246 treatment.
    Zhao W; Tang X; Zhang L
    J Infect; 2024 Feb; 88(2):203-205. PubMed ID: 38103650
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of tecovirimat (ST-246) in nonhuman primates infected with variola virus (Smallpox).
    Mucker EM; Goff AJ; Shamblin JD; Grosenbach DW; Damon IK; Mehal JM; Holman RC; Carroll D; Gallardo N; Olson VA; Clemmons CJ; Hudson P; Hruby DE
    Antimicrob Agents Chemother; 2013 Dec; 57(12):6246-53. PubMed ID: 24100494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adamantane derivatives as potential inhibitors of p37 major envelope protein and poxvirus reproduction. Design, synthesis and antiviral activity.
    Shiryaev VA; Skomorohov MY; Leonova MV; Bormotov NI; Serova OA; Shishkina LN; Agafonov AP; Maksyutov RA; Klimochkin YN
    Eur J Med Chem; 2021 Oct; 221():113485. PubMed ID: 33965861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applications.
    Russo AT; Grosenbach DW; Chinsangaram J; Honeychurch KM; Long PG; Lovejoy C; Maiti B; Meara I; Hruby DE
    Expert Rev Anti Infect Ther; 2021 Mar; 19(3):331-344. PubMed ID: 32882158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SAMD9 is an innate antiviral host factor with stress response properties that can be antagonized by poxviruses.
    Liu J; McFadden G
    J Virol; 2015 Feb; 89(3):1925-31. PubMed ID: 25428864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tecovirimat Resistance in Mpox Patients, United States, 2022-2023.
    Smith TG; Gigante CM; Wynn NT; Matheny A; Davidson W; Yang Y; Condori RE; O'Connell K; Kovar L; Williams TL; Yu YC; Petersen BW; Baird N; Lowe D; Li Y; Satheshkumar PS; Hutson CL
    Emerg Infect Dis; 2023 Dec; 29(12):2426-2432. PubMed ID: 37856204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adventures with poxviruses of vertebrates.
    Fenner F
    FEMS Microbiol Rev; 2000 Apr; 24(2):123-33. PubMed ID: 10717311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecule of the month. Tecovirimat.
    Drug News Perspect; 2008 Nov; 21(9):517. PubMed ID: 19180269
    [No Abstract]   [Full Text] [Related]  

  • 9. Structure of monkeypox virus poxin: implications for drug design.
    Duchoslav V; Boura E
    Arch Virol; 2023 Jun; 168(7):192. PubMed ID: 37378908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with the smallpox antiviral tecovirimat (ST-246) alone or in combination with ACAM2000 vaccination is effective as a postsymptomatic therapy for monkeypox virus infection.
    Berhanu A; Prigge JT; Silvera PM; Honeychurch KM; Hruby DE; Grosenbach DW
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4296-300. PubMed ID: 25896687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptors for gamma-interferon encoded by poxviruses: implications for the unknown origin of vaccinia virus.
    Alcamí A; Smith GL
    Trends Microbiol; 1996 Aug; 4(8):321-6. PubMed ID: 8856871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutants of poxviruses resistant to acetone and N-methyl-isatin-beta-thiosemicarbazone.
    Ghendon YZ; Chernos VI
    Acta Virol; 1972 Jul; 16(4):308-12. PubMed ID: 4403172
    [No Abstract]   [Full Text] [Related]  

  • 13. Evolution and diversity of nucleotide and dinucleotide composition in poxviruses.
    Molteni C; Forni D; Cagliani R; Bravo IG; Sironi M
    J Gen Virol; 2023 Oct; 104(10):. PubMed ID: 37792576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tecovirimat: First Global Approval.
    Hoy SM
    Drugs; 2018 Sep; 78(13):1377-1382. PubMed ID: 30120738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of ST-246 versus lethal poxvirus challenge in immunodeficient mice.
    Grosenbach DW; Berhanu A; King DS; Mosier S; Jones KF; Jordan RA; Bolken TC; Hruby DE
    Proc Natl Acad Sci U S A; 2010 Jan; 107(2):838-43. PubMed ID: 20080762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zoonotic poxvirus infections in humans.
    Lewis-Jones S
    Curr Opin Infect Dis; 2004 Apr; 17(2):81-9. PubMed ID: 15021045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Use of Tecovirimat (Tpoxx) for Treatment of Monkeypox Under an Investigational New Drug Protocol - United States, May-August 2022.
    O'Laughlin K; Tobolowsky FA; Elmor R; Overton R; O'Connor SM; Damon IK; Petersen BW; Rao AK; Chatham-Stephens K; Yu P; Yu Y;
    MMWR Morb Mortal Wkly Rep; 2022 Sep; 71(37):1190-1195. PubMed ID: 36107794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccinia virus inhibitors as a paradigm for the chemotherapy of poxvirus infections.
    De Clercq E
    Clin Microbiol Rev; 2001 Apr; 14(2):382-97. PubMed ID: 11292644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Overview of Antivirals against Monkeypox Virus and Other Orthopoxviruses.
    Wang J; Shahed-Ai-Mahmud M; Chen A; Li K; Tan H; Joyce R
    J Med Chem; 2023 Apr; 66(7):4468-4490. PubMed ID: 36961984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental results of the stability of poxviruses under laboratory and environmental conditions].
    Mahnel H
    Zentralbl Veterinarmed B; 1987 Aug; 34(6):449-64. PubMed ID: 3439393
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.